BNTC
Price
$13.69
Change
-$0.21 (-1.51%)
Updated
Apr 25, 03:03 PM (EDT)
Capitalization
354.97M
MLTX
Price
$38.66
Change
-$0.80 (-2.03%)
Updated
Apr 25, 02:39 PM (EDT)
Capitalization
2.5B
13 days until earnings call
Ad is loading...

BNTC vs MLTX

Header iconBNTC vs MLTX Comparison
Open Charts BNTC vs MLTXBanner chart's image
Benitec Biopharma
Price$13.69
Change-$0.21 (-1.51%)
Volume$100
Capitalization354.97M
MoonLake Immunotherapeutics
Price$38.66
Change-$0.80 (-2.03%)
Volume$500
Capitalization2.5B
BNTC vs MLTX Comparison Chart
Loading...
BNTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNTC vs. MLTX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTC is a Hold and MLTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (BNTC: $13.90 vs. MLTX: $39.45)
Brand notoriety: BNTC and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTC: 70% vs. MLTX: 85%
Market capitalization -- BNTC: $354.97M vs. MLTX: $2.5B
BNTC [@Biotechnology] is valued at $354.97M. MLTX’s [@Biotechnology] market capitalization is $2.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTC’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • BNTC’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BNTC is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTC’s TA Score shows that 7 TA indicator(s) are bullish while MLTX’s TA Score has 6 bullish TA indicator(s).

  • BNTC’s TA Score: 7 bullish, 3 bearish.
  • MLTX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, BNTC is a better buy in the short-term than MLTX.

Price Growth

BNTC (@Biotechnology) experienced а +1.05% price change this week, while MLTX (@Biotechnology) price change was +2.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.06%. For the same industry, the average monthly price growth was -4.34%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

BNTC is expected to report earnings on Sep 27, 2023.

MLTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($2.5B) has a higher market cap than BNTC($355M). BNTC YTD gains are higher at: 10.016 vs. MLTX (-27.147). BNTC has higher annual earnings (EBITDA): -23.8M vs. MLTX (-141.71M). MLTX has more cash in the bank: 448M vs. BNTC (78.3M). BNTC has less debt than MLTX: BNTC (137K) vs MLTX (2.83M). BNTC (0) and MLTX (0) have equivalent revenues.
BNTCMLTXBNTC / MLTX
Capitalization355M2.5B14%
EBITDA-23.8M-141.71M17%
Gain YTD10.016-27.147-37%
P/E RatioN/AN/A-
Revenue00-
Total Cash78.3M448M17%
Total Debt137K2.83M5%
FUNDAMENTALS RATINGS
BNTC: Fundamental Ratings
BNTC
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNTCMLTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
62%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
57%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 18 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
55%
View a ticker or compare two or three
Ad is loading...
BNTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEGCX19.09N/A
N/A
Invesco EQV Intl Small Company C
AMEIX29.99N/A
N/A
American Century Equity Growth I
USNQX46.01N/A
N/A
Victory NASDAQ-100 Index
EFCNX17.76N/A
N/A
Emerald Insights Investor
TNXIX16.28N/A
N/A
1290 Avantis U.S. Large Cap Growth I

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-0.15%
XENE - MLTX
47%
Loosely correlated
+1.62%
CLDX - MLTX
45%
Loosely correlated
+0.77%
KYMR - MLTX
42%
Loosely correlated
+9.32%
IDYA - MLTX
42%
Loosely correlated
+1.33%
DNLI - MLTX
41%
Loosely correlated
+4.17%
More